Home » Stocks » TWST

Twist Bioscience Corporation (TWST)

Stock Price: $190.64 USD -3.89 (-2.00%)
Updated Jan 22, 2021 4:00 PM EST - Market closed
After-hours: $190.50 -0.14 (-0.07%) Jan 22, 7:57 PM
Market Cap 9.27B
Revenue (ttm) 90.10M
Net Income (ttm) -139.93M
Shares Out 39.19M
EPS (ttm) -3.57
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 22
Last Price $190.64
Previous Close $194.53
Change ($) -3.89
Change (%) -2.00%
Day's Open 192.09
Day's Range 186.00 - 193.40
Day's Volume 753,160
52-Week Range 19.71 - 207.97

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 4 days ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA usi...

Business Wire - 1 week ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA usi...

Business Wire - 2 weeks ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #COVID19--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA...

Business Wire - 2 weeks ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA usi...

Business Wire - 1 month ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #COVID19--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA...

Business Wire - 1 month ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNADataStorage--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthe...

The Motley Fool - 1 month ago

Investors favored coronavirus vaccine work, late-stage trial victories, and genetic sequencing.

Other stocks mentioned: INO, MCRB, NVAX, PFE
Business Wire - 1 month ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA usi...

Business Wire - 1 month ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA usi...

Business Wire - 1 month ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA usi...

Business Wire - 1 month ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA usi...

Seeking Alpha - 1 month ago

These stocks look ripe for a 2021 breakout. Seeking Alpha Top Stocks makes it easy to find the strongest stocks in the market.

Other stocks mentioned: CELH, GRBK, TSM
Business Wire - 1 month ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA usi...

Seeking Alpha - 1 month ago

Twist Bioscience Corporation (TWST) CEO Emily Leprouston Q4 2020 Results - Earnings Call Transcript

Benzinga - 2 months ago

Shares of Twist Bioscience (NASDAQ:TWST) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share increased 43.75% year over year to ($0.54), which beat the e...

Business Wire - 2 months ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA usi...

Business Wire - 2 months ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (Nasdaq: TWST) today announced preclinical data for three of its proprietary antibodies against the S1 protein...

Benzinga - 2 months ago

On Monday, November 23, Twist Bioscience (NASDAQ: TWST) will report its last quarter's earnings. Here is Benzinga's preview of the company's release.

Business Wire - 2 months ago

SOUTH SAN FRANCISCO, Calif. & NEW YORK--(BUSINESS WIRE)-- #COVID19--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality sy...

Business Wire - 2 months ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), today announced that it ranked 60th on Deloitte's Technology Fast 500™, a ranking of the 500 f...

Zacks Investment Research - 2 months ago

Twist Bioscience (TWST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 2 months ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA usi...

Business Wire - 2 months ago

SAN FRANCISCO & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DN...

Business Wire - 2 months ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), Illumina, Inc. (NASDAQ: ILMN) and Western Digital (NASDAQ: WDC) today announced the formation ...

Other stocks mentioned: ILMN, WDC
Business Wire - 2 months ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA usi...

Business Wire - 2 months ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA usi...

Business Wire - 2 months ago

SAN FRANCISCO--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon...

Business Wire - 2 months ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (Nasdaq: TWST) and Beyond Earth, an artist collective, today announced a project to store high-resolution artw...

Business Wire - 3 months ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA usi...

Business Wire - 3 months ago

SOUTH SAN FRANCISCO, Calif. & AMSTERDAM & NEW YORK--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-qu...

Business Wire - 4 months ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silic...

Seeking Alpha - 4 months ago

Twist Bioscience: New Profitability Oriented Management & Direction Compensates For The 435% Share-Premium

Seeking Alpha - 4 months ago

Company has 9 new partnerships in first 9 months against a goal of 5-10 in the fiscal year.

Business Wire - 4 months ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA usi...

Business Wire - 4 months ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #COVID19--Twist Bioscience Corporation (Nasdaq: TWST) today announced data demonstrating the potent neutralizing effects of multiple potential th...

The Motley Fool - 5 months ago

The DNA synthesis leader is rapidly expanding its product offerings, but losses continue to grow. Maybe it doesn't matter after all.

Seeking Alpha - 5 months ago

Twist Bioscience Corporation (TWST) CEO Emily Leproust on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 5 months ago

Twist Bioscience (TWST) delivered earnings and revenue surprises of 6.94% and 56.89%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Business Wire - 5 months ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA usi...

The Motley Fool - 5 months ago

Can the company possibly live up to its lofty market valuation?

Business Wire - 5 months ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA usi...

Zacks Investment Research - 5 months ago

Twist Bioscience (TWST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 5 months ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA usi...

Benzinga - 5 months ago

Twist Bioscience (NASDAQ: TWST) shares are trading higher on Tuesday after the company announced the launch of two coronavirus antibody panels to expedite research for COVID-19.

Business Wire - 5 months ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA usi...

Business Wire - 6 months ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA usi...

The Motley Fool - 6 months ago

The company's $2.7 billion valuation is being driven by the coronavirus pandemic and federal stimulus. It doesn't appear sustainable.

Business Wire - 6 months ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #COVID19--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA...

Business Wire - 6 months ago

SOUTH SAN FRANCISCO, Calif. & BOSTON, Mass.

Business Wire - 6 months ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #Antibodies--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic ...

About TWST

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has a collaboration agreement with ImmunoPrecise Antibodies Ltd. Twist Bioscience Corporation was founded in 2013 and ... [Read more...]

Industry
Diagnostics & Research
IPO Date
Oct 31, 2018
CEO
Emily Leproust
Employees
525
Stock Exchange
NASDAQ
Ticker Symbol
TWST
Full Company Profile

Financial Performance

In 2020, TWST's revenue was $90.10 million, an increase of 65.67% compared to the previous year's $54.39 million. Losses were -$139.93 million, 30.0% more than in 2019.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for TWST stock is "Buy." The 12-month stock price forecast is 116.25, which is a decrease of -39.02% from the latest price.

Price Target
$116.25
(-39.02% downside)
Analyst Consensus: Buy